Identification of Inhibitors and Drug Targets for Human Adenovirus Infections

Area of Science:

• Virology
• Drug Discovery
• Infectious Diseases

Background:

• Adenoviruses cause widespread infections across all age groups and seasons.
• Illnesses range from mild to severe, with higher risks for children and immunocompromised individuals.
• Current treatment options are limited, lacking approved drugs or vaccines for adenovirus infections.

Purpose of the Study:

• To identify novel antiviral compounds against adenovirus types 3 and 5.
• To discover potential host targets crucial for adenovirus replication.
• To lay the groundwork for developing new therapeutics against adenovirus infections.

Main Methods:

• Screening of a 2138-compound drug library using a cell-based assay.
• Identification of initial hits inhibiting adenovirus types 3 and 5.
• Secondary screening to confirm antiviral activity and identify targeted host factors.

Main Results:

• 131 compounds showed inhibitory activity against adenoviruses in the primary screen.
• 59 compounds confirmed antiviral effects, inhibiting adenovirus replication.
• Key targeted host factors include heat shock protein, protein tyrosine kinase, and the mTOR signaling pathway.

Conclusions:

• Identified adenovirus inhibitors provide a starting point for new antiviral drug development.
• Targeting host factors like heat shock protein and mTOR signaling may be effective against adenoviruses.
• Further validation of these targets is essential for developing novel therapeutics for adenovirus infections.